drugset / Trial / NCT04653181

Preoperative i.v. Iron Substitution in Patients With Colon Cancer

NCT04653181

RandomizedParallel-groupOpen-labelTreatment

Summary

About 70% of colon cancer patients are anemic. Preoperative anemia in patients with colorectal cancer is associated with both impaired disease-free survival and overall survival. The purpose of this study is to compare the effects of preoperative iv iron substitution on postoperative recovery in preoperatively anemic (male Hb \<130, female Hb \<120) and iron deficient colon cancer patients in a prospective setup. As a primary outcome, the effect of iv-iron substitution on postoperative complications is investigated.

Timeline

Start
2020-10-01
Primary completion
2024-12-31
Completion
2025-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ferric carboxymaltose Other / unclassified Intravenous

Indications